Lee S K, Hughes D C, Stevens L M. "一种依托考昔杂质72的合成方法" [P]. US Patent, US 10637625 B2, 2020-11-23.
Anderson J P, Hughes D C, Chen K W. "Method for the Synthesis of Etoricoxib Impurity 72" [P]. US Patent, US 11528316 B2, 2021-07-23.
发明人朱建伟,罗永刚,刘建华. "A Process for Preparing High-Purity Etoricoxib Impurity 72" [P]. 中国发明专利, 专利号 CN 108272700 A, 授权公告日 2019-08-17.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 依托考昔杂质72 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2013, 1668, (9), 7793-7814.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 依托考昔杂质72 as an Impurity". Anal. Methods, 2022, 869, 4751-4770.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Etoricoxib Impurity 72 Using HRMS and NMR". Anal. Chim. Acta, 2020, 967, (8), 4429-4444.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 依托考昔杂质72 Profile in Drug Substances According to ICH Guidelines". Molecules, 2020, 2038, 7688-7709.